Trevi Therapeutics Inc (OQ:TRVI)

Business Focus: Biopharmaceuticals

Competitors with Recent Insider Filings
Biogen (OQ:BIIB)
BioMarin Pharmaceutical (OQ:BMRN)
Allakos (OQ:ALLK)
Latest 10 SEC filings (by transaction date) for TRVI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 27th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 13/19 May 13/19 Oshea William J Direct Ownership Series C Preferred Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
May 13/19 May 13/19 Oshea William J Direct Ownership Series A Preferred Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
May 13/19 May 13/19 Oshea William J Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
May 13/19 May 9/19 Walker Paul Edward Indirect Ownership Series C Preferred Stock C - Conversion -17,099,315  
May 13/19 May 9/19 Walker Paul Edward Indirect Ownership Common Stock P - Open market or private purchase 1,500,000 $10.00
May 13/19 May 9/19 Walker Paul Edward Indirect Ownership Common Stock P - Open market or private purchase 1,000,000 $10.00
May 13/19 May 9/19 Walker Paul Edward Indirect Ownership Common Stock C - Conversion 1,938,562  
May 13/19 May 9/19 Sonsini Peter W. Indirect Ownership Series C Preferred Stock C - Conversion -17,099,315  
May 13/19 May 9/19 Sonsini Peter W. Indirect Ownership Common Stock P - Open market or private purchase 1,500,000 $10.00
May 13/19 May 9/19 Sonsini Peter W. Indirect Ownership Common Stock P - Open market or private purchase 1,000,000 $10.00
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for TRVI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 27th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 13/19 May 9/19 Walker Paul Edward Indirect Ownership Series C Preferred Stock C - Conversion -17,099,315  
May 13/19 May 9/19 Walker Paul Edward Indirect Ownership Common Stock P - Open market or private purchase 1,500,000 $10.00
May 13/19 May 9/19 Walker Paul Edward Indirect Ownership Common Stock P - Open market or private purchase 1,000,000 $10.00
May 13/19 May 9/19 Walker Paul Edward Indirect Ownership Common Stock C - Conversion 1,938,562  
May 13/19 May 9/19 Sonsini Peter W. Indirect Ownership Series C Preferred Stock C - Conversion -17,099,315  
May 13/19 May 9/19 Sonsini Peter W. Indirect Ownership Common Stock P - Open market or private purchase 1,500,000 $10.00
May 13/19 May 9/19 Sonsini Peter W. Indirect Ownership Common Stock P - Open market or private purchase 1,000,000 $10.00
May 13/19 May 9/19 Sonsini Peter W. Indirect Ownership Common Stock C - Conversion 1,938,562  
May 13/19 May 9/19 Sandell Scott D Indirect Ownership Series C Preferred Stock C - Conversion -17,099,315  
May 13/19 May 9/19 Sandell Scott D Indirect Ownership Common Stock P - Open market or private purchase 1,500,000 $10.00
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $TRVI

StockTwits